Abstract
Objective: To analyze anxiety disorders such as generalized anxiety disorder, panic and social anxiety. Bibliographic review: Anxiety disorders are the most common type of mental illness with 61.5 million people affected. These comprise separation anxiety and selective mutism, specific phobias, social anxiety disorder (SAD) and generalized anxiety disorder (GAD), as well as panic disorder (PD). SAD is characterized by persistent fear of social situations due to anticipation of negative judgment by others, while GAD is characterized by excessive worry coupled with disproportionate fear in everyday situations, and PD is composed of unexpected panic attacks that have rapid onset and are short-lived. Final considerations: Anxiety disorders are phenomena that lead to a great loss of quality of life, arising from worry and excessive fear in the face of certain situations. The main anxiety disorders are: social anxiety disorder, generalized anxiety disorder and panic disorder. The treatment of these conditions is done through pharmacotherapy with selective serotonin reuptake inhibitors, benzodiazepines and psychotherapy with cognitive behavioral therapy.
References
AHMED M, et al. The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics. Braz J Psychiatry, 2022; 44(1): 81-93.
ALOMARI NA, et al. Social Anxiety Disorder: Associated Conditions and Therapeutic Approaches. Cureus, 2022; 14(12): e32687.
BAKER HJ, et al. Adolescents' lived experience of panic disorder: an interpretative phenomenological analysis. BMC Psychol, 2022; 10(1): 143.
BASILE VT, et al. Remote cognitive-behavioral therapy for generalized anxiety disorder: A preliminary meta-analysis. J Clin Psychol, 2022; 78(12): 2381-2395.
CALDIROLA D, et al. Experimental Drugs for Panic Disorder: An Updated Systematic Review. J Exp Pharmacol, 2021; 13: 441-459.
CHAWLA N, et al. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. BMJ, 2022; 376: e066084.
CLARK AE, et al. A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder. J Dual Diagn, 2021; 17(4): 313-332.
COSTA CO, et al. Prevalência de ansiedade e fatores de risco associados em adultos. J Bras Psiquiatr, 2019; 68: 92 – 100.
COSTA MA, MANFRO GG. Generalized anxiety disorder: advances in neuroimaging studies. Braz J Psychiatry, 2019; 41(4): 279.
CROCKETT MA, et al. Psychometric properties of the Generalized Anxiety Disorder 7-item (GAD-7) scale in Chilean adolescents. Rev Med Chil, 2022; 150(4): 458-464.
GARAKANI A, et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry, 2020; 11: 595584.
GHAHARI S, et al. Mindfulness-based Cognitive Therapy for Generalised Anxiety Disorder: a Systematic Review and Meta-analysis. East Asian Arch Psychiatry, 2020; 30(2): 52-56.
KIM N, KIM MJ. Altered Task-Evoked Corticolimbic Responsivity in Generalized Anxiety Disorder. Int J Mol Sci, 2021; 22(7): 3630.
KOYUNCU A, et al. Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges. Drugs Context, 2019; 8: 212573.
KRIEGEL DL, AZRAK A. Benzodiazepines for Panic Disorder in Adults. Am Fam Physician, 2020; 101(7).
LOPES AB, et al. Transtorno de ansiedade generalizada: uma revisão narrativa. REAC, 2021; 35: e8773.
MARON E, NUTT D. Biological markers of generalized anxiety disorder. Dial Clin, 2017; 19(2): 147-158.
MASDRAKIS VG, BALDWIN DS. Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review. Ther Adv Psychopharmacol, 2021; 11: 20451253211002320.
MITSUI N, et al. Antidepressants for social anxiety disorder: A systematic review and meta-analysis. Neuropsychopharmacol Rep, 2022; 42(4): 398-409.
PENNINX BW, et al. Anxiety disorders. Lancet, 2021; 397(10277): 914-927.
STEIN DJ. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine. Adv Ther, 2021; 38(2): 52-60.
STRAWN JR, et al. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother, 2018; 19(10): 1057-1070.
STROHLE A, et al. The Diagnosis and Treatment of Anxiety Disorders. Dtsch Arztebl Int, 2018; 155(37): 611-620.
